This HTML5 document contains 52 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n17http://localhost/temp/predkladatel/
n13http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n14http://linked.opendata.cz/ontology/domain/vavai/
n15http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216208%3A11110%2F01%3A00111451%21RIV%2F2002%2FMSM%2F111102%2FN/
n8http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n4http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n7http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n5http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n11http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216208%3A11110%2F01%3A00111451%21RIV%2F2002%2FMSM%2F111102%2FN
rdf:type
skos:Concept n14:Vysledek
dcterms:description
minomal residual disease, polymerase chain reaction, autologous stem cell transplantation minomal residual disease, polymerase chain reaction, autologous stem cell transplantation
dcterms:title
Anti CD20 Antibody (Rituximab) Therapy Leads to High Molecular Remission Rate with Favourable Outcome in Patients with Non-Hodgkin's Lymphoma Anti CD20 Antibody (Rituximab) Therapy Leads to High Molecular Remission Rate with Favourable Outcome in Patients with Non-Hodgkin's Lymphoma
skos:prefLabel
Anti CD20 Antibody (Rituximab) Therapy Leads to High Molecular Remission Rate with Favourable Outcome in Patients with Non-Hodgkin's Lymphoma Anti CD20 Antibody (Rituximab) Therapy Leads to High Molecular Remission Rate with Favourable Outcome in Patients with Non-Hodgkin's Lymphoma
skos:notation
RIV/00216208:11110/01:00111451!RIV/2002/MSM/111102/N
n3:strany
605A;606A
n3:aktivita
n5:Z
n3:aktivity
Z(MSM 111100004)
n3:cisloPeriodika
11, Part 1
n3:dodaniDat
n11:2002
n3:domaciTvurceVysledku
n13:7163045 n13:1018426 n13:6817025
n3:druhVysledku
n9:J
n3:duvernostUdaju
n7:S
n3:entitaPredkladatele
n15:predkladatel
n3:idSjednocenehoVysledku
673462
n3:idVysledku
RIV/00216208:11110/01:00111451
n3:jazykVysledku
n12:eng
n3:klicovaSlova
Antibody;Rituximab;Therapy;Leads;Molecular;Remission;Favourable;Outcome;Patients;Non-Hodgkin's;Lymphoma
n3:klicoveSlovo
n4:Favourable n4:Non-Hodgkin%27s n4:Leads n4:Outcome n4:Molecular n4:Patients n4:Remission n4:Rituximab n4:Antibody n4:Therapy n4:Lymphoma
n3:kodStatuVydavatele
US - Spojené státy americké
n3:kontrolniKodProRIV
[5576461572BE]
n3:nazevZdroje
Blood
n3:obor
n18:FD
n3:pocetDomacichTvurcuVysledku
3
n3:pocetTvurcuVysledku
5
n3:pocetUcastnikuAkce
0
n3:pocetZahranicnichUcastnikuAkce
0
n3:rokUplatneniVysledku
n11:2001
n3:svazekPeriodika
98
n3:tvurceVysledku
Černý, Jan Trněný, Marek Slavíčková, Alena
n3:zamer
n8:MSM%20111100004
s:issn
0006-4971
s:numberOfPages
1
n17:organizacniJednotka
11110